Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Drug Discovery Spotlight: Next Steps for Pfizer, Allergan; Drug Discovery in the Greenhouse

By Drug Discovery Trends Editor | April 8, 2016

Welcome to Drug Discovery Spotlight — we’ve rounded up this week’s top news, trending headlines, and all-around interesting reads.

 

 

Richard Drew/APPfizer, Allergan End Merger Deal

A major update occurred this week when it was reported that both companies mutually agreed to terminate their approximate $160 billion merger, after the U.S. Treasury Department proposed new tax regulations that would reduce the merger’s benefit: mainly, a major cut on the company’s tax bill. Pfizer is to pay Allergan $150 million for reimbursement of expenses associated with the transaction. Since Wednesday’s news, many are speculating on where each company will go from here. The New York Times reported that Pfizer faces limited options in the aftermath, saying the company essentially has two choices: to “get bigger, or break apart.” Meanwhile, Allergan’s CEO Brent Saunders has been vocal, saying his company was targeted by the government, but that “Allergan still has a bright future.” Just yesterday, Allergan announced it struck a $3.3 billion deal with Heptares for its neurological drug portfolio.

Makers Took Big Price Increases on Widely Used U.S. Drugs

This Reuters exclusive focused on how major pharmaceutical companies took “hefty price increases” in the U.S. for widely used medications over the past five years. Price hikes by Turing Pharmaceuticals for Daraprim, an antiparasitic used for rare infection, by 5,000 percent and Valeant’s actions have come under scrutiny as of late. According to a Reuters analysis of proprietary data, prices for four of the nation’s top 10 drugs increased more than 100 percent since 2011, and six others increased more than 50 percent.

In High-Tech Hub, This Scientist Hunts for Cures in the Greenhouse

When you think about today’s drug discovery, you likely imagine high-tech, extensive research. But this STAT article features biologist Jing-Ke Weng, who works at the Whitehead Institute for Biomedical Research searching among plants for the next cure. “He’s determined to harness peanut skins, and twisted roots, and an herb known as horny goat weed — and the strange blooms in a seventh-floor greenhouse — to treat human disease.” Read more.


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE